Parkinson's & Movement disorders

Study identifies chaperone protein implicated in Parkinson's disease

Reduced levels of a chaperone protein might have implications for the development and progression of neurodegenerative diseases such as Parkinson's disease and Lewy body dementia, according to new research from investigators ...

Parkinson's & Movement disorders

Study raises doubts on a previous theory of Parkinson's disease

Parkinson's disease was first described by a British doctor more than 200 years ago. The exact causes of this neurodegenerative disease are still unknown. In a study recently published in eLife, a team of researchers led ...

Parkinson's & Movement disorders

Shedding a tear may help diagnose Parkinson's disease

Tears may hold clues to whether someone has Parkinson's disease, according to a preliminary study released today that will be presented at the American Academy of Neurology's 70th Annual Meeting in Los Angeles, April 21 to ...

Parkinson's & Movement disorders

Tug of war between Parkinson's protein and growth factor

Alpha-synuclein, a sticky and sometimes toxic protein involved in Parkinson's disease (PD), blocks signals from an important brain growth factor, Emory researchers have discovered.

Parkinson's & Movement disorders

Tracing the path of Parkinson's disease proteins

As neurodegenerative disorders such as Parkinson's and Alzheimer's disease progress, misfolded proteins clump together in neurons, recruiting normal proteins in the cell to also misfold and aggregate. Cells in which this ...

Parkinson's & Movement disorders

A new insight into Parkinson's disease protein

Abnormal clumps of certain proteins in the brain are a prominent feature of Parkinson's and other neurodegenerative diseases, but the role those same proteins might play in the normal brain has been unknown.

page 4 from 7